Sign In
Buy ME
$0.606
+0 (+0%)
At Close: Sep 16, 2025
Why 23andMe Rocketed 27.9% Higher in October
03:48pm, Tuesday, 02'nd Nov 2021
The genetics upstart is acquiring a telehealth platform.
Why 23andMe Stock Was Up More Than 9% on Tuesday
06:18pm, Tuesday, 26'th Oct 2021
Investors may see potential in the company's proposed acquisition of telehealth company Lemonaid.
Day Hagan Tech Talk: Volatility of a Different Type
10:17am, Tuesday, 26'th Oct 2021
By Day Hagan Asset Management SUMMARY With corporate earnings coming out in abundance, a plethora of domestic and international narratives, and now, from a price perspective, a short-term overbought c
23andMe to Buy Web Platform Lemonaid Health for $400M
07:25am, Monday, 25'th Oct 2021
Hims & Hers Health has had its biggest one-day loss in over two months, following its rival 23andMe's agreement to buy web-based healthcare platform Lemonaid Health. Hims & Hers is a telehealth platfo
23andme CEO on deal to buy Lemonaid: I love Lemonaid for the pharmacy component
02:55pm, Friday, 22'nd Oct 2021
23andme CEO Anne Wojcicki joins The Exchange to discuss her company's planned acquisition of Lemonaid, a telehealth company, and the future of genetic integration in health. For access to live and exc
Why 23andMe Stock Dropped Today
11:42am, Friday, 22'nd Oct 2021
Fresh off its SPAC IPO, 23andMe is buying another company.
23andMe to buy telehealth firm Lemonaid for $400 million
07:37am, Friday, 22'nd Oct 2021
Direct-to-consumer DNA testing firm 23andMe Holding Co said on Friday it would buy privately held company Lemonaid Health Inc for $400 million in a cash-and-stock deal, as it looks to expand into tele
23andMe buys telemedicine specialist Lemonaid Health
07:20am, Friday, 22'nd Oct 2021
23andMe Holding Co. ME, +1.27% said Friday it agreed to pay $400 million for Lemonaid Health Inc., the on-demand platform for accessing medical care and pharmacy services, in a bid to add telemedicine
Why 23andMe Stock Has Jumped 16% So Far This Week
10:08pm, Thursday, 21'st Oct 2021
A favorable mention on CNBC lit a fire underneath the biotech's stock this week.
23andMe to Report FY2022 Second Quarter Financial Results on November 10, 2021
06:30pm, Wednesday, 20'th Oct 2021
SUNNYVALE, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial r
23andMe Stock Could Be a Big Winner If This 1 Thing Happens
07:45am, Sunday, 17'th Oct 2021
It needs to make money from something bigger than just its genetic test kits.
ME Stock: 6 Things to Know About 23andMe as Shares Shoot Higher Today
02:01pm, Friday, 15'th Oct 2021
23andMe (ME) stock is running higher on Friday as investors pile on with heavy trading thanks to a recent interview on CNBC. The post ME Stock: 6 Things to Know About 23andMe as Shares Shoot Higher To
Why 23andMe Stock Jumped 16% Today
01:40pm, Friday, 15'th Oct 2021
An analyst calls 23andMe's 11 million sample database unique and unprecedented.
3 Stocks That Can Turn $10,000 Into $50,000 by 2025
06:17am, Saturday, 09'th Oct 2021
These stocks are far from sure things, but their potential is undeniable.
23andMe Stock: Continued Drug-Development Progress Can Deliver Long-Term Gains
03:19pm, Sunday, 03'rd Oct 2021
23andMe is well known for their services around DNA testing, ancestry mapping, and genetic data. By collaborating with GlaxoSmithKline, the companies can better use 23andMe's 11.6 million genotyped cu
